Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Lerapolturev by Istari Oncology for High-Grade Glioma: Likelihood of Approval
Lerapolturev is under clinical development by Istari Oncology and currently in Phase II for High-Grade Glioma. According to GlobalData, Phase...
Data Insights
D2C7-IT by Istari Oncology for Glioblastoma Multiforme (GBM): Likelihood of Approval
D2C7-IT is under clinical development by Istari Oncology and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData,...